Cargando…
An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society for Cell & Gene Therapy. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339970/ https://www.ncbi.nlm.nih.gov/pubmed/36028438 http://dx.doi.org/10.1016/j.jcyt.2022.07.010 |
| _version_ | 1784760292463345664 |
|---|---|
| author | Weiss, Daniel J. Filiano, Anthony Galipeau, Jacques Khoury, Maroun Krampera, Mauro Lalu, Manoj Blanc, Katarina Le Nolta, Jan Phinney, Donald G. Rocco, Patricia R.M. Shi, Yufang Tarte, Karin Viswanathan, Sowmya Martin, Ivan |
| author_facet | Weiss, Daniel J. Filiano, Anthony Galipeau, Jacques Khoury, Maroun Krampera, Mauro Lalu, Manoj Blanc, Katarina Le Nolta, Jan Phinney, Donald G. Rocco, Patricia R.M. Shi, Yufang Tarte, Karin Viswanathan, Sowmya Martin, Ivan |
| author_sort | Weiss, Daniel J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9339970 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | International Society for Cell & Gene Therapy. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93399702022-08-01 An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry Weiss, Daniel J. Filiano, Anthony Galipeau, Jacques Khoury, Maroun Krampera, Mauro Lalu, Manoj Blanc, Katarina Le Nolta, Jan Phinney, Donald G. Rocco, Patricia R.M. Shi, Yufang Tarte, Karin Viswanathan, Sowmya Martin, Ivan Cytotherapy Editorial International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2022-11 2022-08-01 /pmc/articles/PMC9339970/ /pubmed/36028438 http://dx.doi.org/10.1016/j.jcyt.2022.07.010 Text en © 2022 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Editorial Weiss, Daniel J. Filiano, Anthony Galipeau, Jacques Khoury, Maroun Krampera, Mauro Lalu, Manoj Blanc, Katarina Le Nolta, Jan Phinney, Donald G. Rocco, Patricia R.M. Shi, Yufang Tarte, Karin Viswanathan, Sowmya Martin, Ivan An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry |
| title | An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry |
| title_full | An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry |
| title_fullStr | An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry |
| title_full_unstemmed | An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry |
| title_short | An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry |
| title_sort | international society for cell and gene therapy mesenchymal stromal cells committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339970/ https://www.ncbi.nlm.nih.gov/pubmed/36028438 http://dx.doi.org/10.1016/j.jcyt.2022.07.010 |
| work_keys_str_mv | AT weissdanielj aninternationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT filianoanthony aninternationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT galipeaujacques aninternationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT khourymaroun aninternationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT kramperamauro aninternationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT lalumanoj aninternationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT blanckatarinale aninternationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT noltajan aninternationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT phinneydonaldg aninternationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT roccopatriciarm aninternationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT shiyufang aninternationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT tartekarin aninternationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT viswanathansowmya aninternationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT martinivan aninternationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT weissdanielj internationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT filianoanthony internationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT galipeaujacques internationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT khourymaroun internationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT kramperamauro internationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT lalumanoj internationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT blanckatarinale internationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT noltajan internationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT phinneydonaldg internationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT roccopatriciarm internationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT shiyufang internationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT tartekarin internationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT viswanathansowmya internationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry AT martinivan internationalsocietyforcellandgenetherapymesenchymalstromalcellscommitteeeditorialonovercominglimitationsinclinicaltrialsofmesenchymalstromalcelltherapyforcoronavirusdisease19timeforaglobalregistry |